Inovare Alpha®
A solution for patients who are in the gap between conventional surgery and TAVI, patients with a small aortic annulus (risk of mismatch), need for concomitant procedures, and minimally invasive surgeries.
Anvisa nº: 10159030095
Indication
- Indicated for patients with Calcified Aortic Valve Stenosis and for replacing the mitral valve through a transcatheter valve-in-valve implant procedure.
Benefits and differentiators
- Reduces surgical time: shorter aortic cross-clamp and cardiopulmonary bypass durations.
- Leaflets manufactured from a single bovine pericardial patch: fewer sutures and larger effective orifice area (EOA).
- Cobalt-chromium alloy: Structure with increased radial force and reduced recoil
- Balloon-expandable delivery system.
- Outer polyester (PET) skirt: Efficient sealing to reduce paravalvular leak
- Large open cells: Facilitate access to the coronary ostium
- Posts with radiopaque markers: Stability, precision, and safety
